WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke QVEQLI wurde als Wortmarke am 18.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1554846 |
| Länder | 
|
| Basismarke |
Nr. VA 2019 02910,
30. Dezember 2019
|
| Anmeldedatum | 18. Juni 2020 |
| Ablaufdatum | 18. Juni 2030 |
Markeninhaber
c/o Ascendis Pharma A/S,
Tuborg Boulevard 5
DK
Tuborg Boulevard 5
DK
Markenvertreter
Vejlsøvej 51
8600 Silkeborg
DK
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of growth
disorders, pharmaceutical preparations for the treatment of
endocrine disorders, pharmaceutical preparations for the
treatment of bone disorders; diagnostic preparations for
medical use, namely, diagnostic preparations for identifying
and detecting growth hormone deficiency, endocrine
disorders, bone disorders, cancer and infectious diseases
09
Computer software and computer programs for use in providing
medical advice and advice on medications for treatment,
patient assistance and health insurance in the field of
growth disorders, endocrine disorders, bone disorders,
cancer, and infectious diseases; computer application
software for mobile phones, tablet computers, handheld
computers and personal computers, namely a downloadable
software application for sharing information related to
growth disorders, endocrine disorders, bone disorders,
cancer, infectious diseases and the treatment of growth
disorders, endocrine disorders, bone disorders, cancer, and
infectious diseases for use by patients with growth hormone
disorders, hypoparathyroidism, skeletal dysplasia, and
diabetes in the medical field of growth disorders, endocrine
disorders, bone disorders, cancer, and infectious diseases;
computer application software for mobile phones, tablet
computers, handheld computers and personal computers,
namely, software that coordinates the delivery of health
care services between health care providers, patients and
those parties responsible for the payment of health care
services, namely software that allows individuals seeking
medical education, information and services to locate a
physician and treatment facility in their geographic area
for medical treatment and allows physicians and health care
professionals to communicate their credentials and
specialization to patients and parties responsible for
payment of healthcare services; computer application
software for mobile phones, tablet computers, handheld
computers and personal computers, namely, software that
enables health care providers to monitor patients,
communicate clinical information relevant to a patient's
care, provide and exchange information concerning patients
and the health care services provided to patients;
downloadable software, software applications and mobile
applications for providing co-pay and other financial or
medical access support; downloadable computer software for
providing a communications platform enabling users to share
health and healthcare information; downloadable software,
software applications and mobile applications for the
measurement of height, weight, blood pressure, serum
calcium, blood glucose, and heart rate; downloadable
software, software applications and mobile applications for
providing, exchanging, retrieving and analyzing health and
healthcare information; software for medical purposes,
namely, for formatting, viewing and transmitting medical
data collected and stored on hormone injection pens and
pumps between injection pens and pumps and portable
electronic devices; computer application software for mobile
phones, tablet computers, handheld computers and personal
computers, namely a downloadable software application for
providing healthcare-related information, medication
reminders, and tracking medication dosing history; the
foregoing related to pharmaceutical preparations for the
treatment of growth disorders, endocrine disorders, bone
disorders, cancer, and infectious diseases
10
Medical devices for injection, dosage and control of
pharmaceuticals, namely medical devices for injection,
dosage and control of pharmaceuticals for the treatment of
growth disorders, endocrine disorders, bone disorders,
cancer, and infectious diseases; syringes for medical
purposes and for injections; syringes for injection for
medical and surgical use, namely syringes in the form of
pens for surgical use; digitally connected medical devices
for monitoring the dosage of pharmaceutical preparations for
use in connection with management of growth hormone
disorders, hypoparathyroidism, skeletal dysplasia, cancer
and diabetes; medical apparatus, namely, infusion and
injection devices for administering drugs; medical apparatus
and instruments for diagnostic purposes namely dosage
management dispensers for medicines containing software for
medical information management for use in web-based physical
and psychological examination and assessment of patients
remotely and in a clinic; dosage management dispensers for
medicines incorporating software for medical information
management for guidance and control of medicines and for
therapeutic use in web-based physical and psychological
examination and assessment of patients remotely and at a
clinic
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 31. März 2022 | 2022/13 Gaz | JP | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 07. Februar 2022 | 2022/7 Gaz | KR | Ablehnung |
| 01. Dezember 2021 | 2022/2 Gaz | RAW: Limitation | |
| 16. September 2021 | 2021/37 Gaz | JP | Ablehnung |
| 16. September 2021 | 2021/37 Gaz | CH | Ablehnung |
| 03. September 2021 | 2021/35 Gaz | NO | Ablehnung |
| 27. Mai 2021 | 2021/21 Gaz | NZ | Ablehnung |
| 05. Februar 2021 | 2021/6 Gaz | CN | Ablehnung |
| 26. Januar 2021 | 2021/4 Gaz | AU | Ablehnung |
| 18. Juni 2020 | 2020/39 Gaz | DK | Eintragung |
ID: 141554846